OCT can characterize corneoscleral junction

June 20, 2014

Article

Optical coherence tomography (OCT) can be used to characterize the angle and topography of the corneoscleral junction, according to newly published research.

Optical coherence tomography (OCT) can be used to characterize the angle and topography of the corneoscleral junction, according to research published in Optometry and Vision Science.

The novel, quantitative method used by the researchers also established differences among quadrants of the ocular surface, and between ethnic groups.

The researchers recruited a total of 48 subjects (16 Asian, 16 White and 16 Latino), and took OCT images in both eyes of the subjects' nasal, temporal, superior and inferior quadrants. Custom image analysis software allowed selection of a point defining the centre of the corneoscleral junction, and 20 concentric circles were drawn from this point. Edge-detection routines located the surface of the junction, and a linear regression was fit to the series of points that defined the circles intersecting this edge. A set of metrics was then calculated based on the regression residuals.

The researchers found that the most repeatable metric was the sum of the squared orthogonalized residuals (SSRo). In addition, this metric was unaffected by the orientation of the image.

The SSRo was greatest (indicating a more pronounced angle and/or rougher surface) in the nasal quadrant (p p

To read an abstract of the study, click here.

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!

Recent Videos

At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients

Early intervention is crucial for long-term outcomes in paediatric gene therapy

$At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery$

Robert Ang, MD, explains why a small-aperture IOL is "not a niche product"

Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.

ARVO 2025: Ocular and systemic mitochondrial diseases may be key to dementia diagnosis

Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).

ARVO 2025: Alfredo Sadun, MD, PhD, says "later is better" for some LHON interventions

At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.

ARVO 2025: Nitish Mehta, MD, provides real-world insights from aflibercept 8 mg for treatment-naive diabetic macular oedema

ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy

ARVO 2025: Anat Loewenstein, MD, and colleagues on meeting needs of patients with diabetic retinopathy

$At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study$

Sheng Lim, MD, FRCOphth, brings data from the CONCEPT study to the ASCRS meeting